Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase NA 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Urologic Diseases 1Urinary Retention 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Prostatic Neoplasms 1Patient Satisfaction 1Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Hematuria 1

Interventions

pembrolizumab 44Nivolumab 29Gemcitabine 28Paclitaxel 19Cisplatin 18Ipilimumab 15Carboplatin 14Cyclophosphamide 13Capecitabine 12Dexamethasone 10Bevacizumab 10cemiplimab 9Irinotecan 9Docetaxel 9Albumin-Bound Paclitaxel 9130-nm albumin-bound paclitaxel 9spartalizumab 8Pemetrexed 8Sorafenib 7Rituximab 7Cetuximab 7fludarabine 6Temozolomide 6Taxes 6Radiotherapy 6Leucovorin 6Fluorouracil 6Azacitidine 6Ascorbic Acid 6lenvatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms × Tranexamic Acid × Clear all
NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

University of Pittsburgh

Phase 1/2 Terminated
11 enrolled 15 charts
Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡